Inactive Instrument
Acticor Biotech SAS Stock Euronext Paris
Stocks
ALACT
FR0014005OJ5
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
CEO | Chief Executive Officer | - | 26/11/2013 |
Francois Guillet
DFI | Director of Finance/CFO | 68 | 13/10/2024 |
Anouar Sari
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
BRD | Director/Board Member | - | 26/11/2013 |
Alain Parthoens
BRD | Director/Board Member | 66 | 24/10/2018 |
Catherine Boule
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 12.69M | ||
| +2.38% | +3.43% | +82.88% | +115.89% | 73.96B | ||
| +1.24% | +22.84% | +55.73% | +96.67% | 64.66B | ||
| +0.64% | +1.17% | -5.59% | +469.05% | 27.32B | ||
| +6.14% | +23.63% | +3.90% | -2.08% | 27.86B | ||
| +2.74% | +12.98% | +62.84% | +28.14% | 25.97B | ||
| +0.84% | +5.72% | +36.15% | -14.11% | 19.98B | ||
| -1.79% | -4.84% | +239.54% | +414.48% | 17.84B | ||
| +0.94% | +3.36% | +18.55% | +532.94% | 16.24B | ||
| +0.56% | +5.00% | +38.98% | +151.75% | 13.3B | ||
| Average | +1.35% | +6.18% | +59.22% | +199.19% | 31.9B | |
| Weighted average by Cap. | +1.81% | +8.21% | +59.68% | +160.54% |
Employees
31
















